期刊文献+

胰腺癌病人心率变异性变化及其临床意义研究(附518例分析) 被引量:3

Clinical significance of heart rate variability change in pancreatic cancer patients:An analysis of 518 cases
原文传递
导出
摘要 目的探讨胰腺癌病人心率变异性(HRV)的变化及其在临床中的价值。方法回顾性分析2008年1月至2013年5月浙江大学医学院附属第二医院收治的518例胰腺癌病人临床资料。以性别、年龄、癌症分期及癌症是否远处转移分组,对比不同组内的HRV指标,包括全部正常窦性心搏间期的标准差(SDNN)和全部相邻RR间期之差的均方根(r RMSSD)。以SDNN=20 ms为界分为低HRV组和高HRV组,比较两组间C反应蛋白(CRP)及肿瘤直径的统计学意义。结果胰腺癌早期病人、胰腺癌未转移病人的HRV值分别高于胰腺癌晚期病人(P<0.001)及胰腺癌已转移病人(P=0.011)HRV值,并且在低HRV组中观察到CRP显著升高(P=0.008)。结论胰腺癌的恶性程度与HRV的水平变化有关,低HRV的病人预后较差,这可能与迷走神经兴奋抑制炎性反应的机制有关。 Objective To evaluate the clinical value of heart rate variability change in the patients with pancreatic cancer. Methods The clinical data of 518 cases of pancreatic cancer admitted from January 2008 to May 2013 in the Second Affiliated Hospital of Zhejiang University School of Medicine were analyzed retrospectively. The moderating effects of gender,age,cancer stages and distant metastasis on HRV including standard diviation of NN intervals (SDNN) and root mean square of successive differences(RMSSD)were examined. The statistical significance of C-ractiveprotein (CRP)and tumor diameter between low HRV group and high HRV group using the cut-off of SDNN=20ms were tested. Results HRV values in cancer patients with early stage was higher than those with advanced stages significantly (P〈0.001). HRV values in cancer patients without metastasis had significant higher HRV than those with metastases (P=0.011). CRP was higher in low HRV group than that in high HRV group(P=0.008). Conclusion The later the stage of pancreatic cancer patients is,the more the index of HRV declines, which may be related to the mechanism that vagal nerve excitement inhibits inflammatory reaction.
出处 《中国实用外科杂志》 CSCD 北大核心 2014年第12期1179-1182,共4页 Chinese Journal of Practical Surgery
基金 国家自然科学基金(No.81272671) 国家卫生和计划生育委员会科研基金(No.WKJ2013-2-018)
关键词 胰腺癌 心率变异性 迷走神经 C反应蛋白 pancreatic cancer HRV vagal nerve CRP
  • 相关文献

参考文献18

  • 1De Couck M, Gidron Y.Norms of vagal nerve activity, indexed by Heart Rate Variability, in cancer patients [J ].Cancer Epidemiol, 2013,37(5): 737-741.
  • 2Walsh D, Nelson KA.Autonomic nervous system dysfunction in advanced cancer[ J ].Support Care Cancer, 2002,10(7) : 523-528.
  • 3赵玉沛.胰腺癌诊治指南[J].中国实用外科杂志,2007,27(9):671-673. 被引量:48
  • 4Mouton C, Ronson A, Razavi D, et al.The relationship between heart rate variability and time-course of carcinoembryonic anti- gen in colorectal cancer [J]. Auton Neurosci, 2012, 166(1-2): 96-99.
  • 5全国心率变异性分析多中心研究协作组,尹彦琳,吴宁,程康安,黄从新,王晋明,蒋文平,刘志华,吕卓人,薛小临,杨钧国,吴俞萍,陆再英,张黎,李莉,王铁锚,黄永麟,曲秀芬,朴晶燕,高冠宇,刘莹.心率变异性正常值及其重复性的多中心研究[J].中华心律失常学杂志,2000,4(3):165-170. 被引量:111
  • 6Kimdo H, Kim JA, Choi YS, et al.Heart rate variability and length of surcival in hospice cancer patients [J].J Korean Med Sci, 2010,25(8) : 1140-1145.
  • 7Gidron Y, Perry H, Glennie M.Does the vagus nerve inform the brain about preclinical tumours and modulate them? [J].Lancet Oncol, 2005,6(4): 245-248.
  • 8Tracey KJ.The inflammatory reflex [ J ].Nature, 2002,420(6917) : 853-859.
  • 9Chiang JK, Koo M, Kuo TB, et al. Association between cardio-vascular autonomic functions and time to death in patients with terminal hepatocellular carcinoma [J ] .J Pain Symptom Manage, 2010,39(4) : 673-679.
  • 10Hansen MV, Rosenberg J, Gogenur I. Lack of circadian varia- tion and reduction of heart rate variability in women with breast cancer undergoing lumpectomy: a descriptive study [J]. Breast Cancer Res Treat,2013,140(2): 317-322.

二级参考文献36

  • 1曲秀芬,黄永麟,宋丽云,朴晶艳,纪树彦.心率变异性功率谱不同计算方法及某些成分临床意义的探讨(摘要)[J].中华心律失常学杂志,1998,2(2):104-104. 被引量:6
  • 2张坤,余佩武,高朋芬,饶云.胃癌细胞-树突状细胞融合疫苗对肿瘤细胞增殖周期影响的研究[J].中华胃肠外科杂志,2006,9(4):345-348. 被引量:3
  • 3Falconer JS, Fearon KC, Plester CE, et al. Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer. Ann Surg, 1994,219(2):325-331
  • 4Crucitti F, Doglietto GB, Viola G, et al. Assessment of risk factors for pancreatic resection in cancer. World J Surg, 1998,22(3):241-247
  • 5The Veterans Affairs Total Parenteral Nutrition Cooperative Study Group. Perioperative total parenteral nutrition in surgical patients. N Engl J Med, 1991,325(8):525-532
  • 6Von Meyenfeldt MF, Meijering WJHJ, Rouflart MMJ, et al. Perioperative nutritional support: a randomised clinical trial. Clin Nutr,1992,11(2):180-186
  • 7Sandstrom R, Drott C, Hyltander A, et al. The effect of postoperative intravenous feeding (TPN) on outcome following major surgery evaluated in a randomized study. Ann Surg, 1993,217(2):185-195
  • 8van Berge Henegouwen MI, Akkermans LM, van Gulik TM, et al. Prospective randomized trial on the effect of cyclic versus continuous enteral nutrition on postoperative gastric function after pylorus-preserving pancreatoduodenectomy. Ann Surg ,1997,226(5):67
  • 9Gianotti L, Braga M, Gentilini O, et al. Artificial nutrition after pancreaticoduodenectomy. Pancreas, 2000,21(4):344-351
  • 10Jemal A, Siegel R, Ward E, et al. Cancer statistics [J]. CA Cancer J Clin,2006,56(2) :106-130.

共引文献174

同被引文献29

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部